• 104
  • 13
  • 收藏

Moderna Edges Pfizer in Study of Five Covid Vaccines

Bloomberg2021-11-26

TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.

Moderna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.

The research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.

“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.

Pfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.

AstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.

Both AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.

Hungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论13

  • Universe宇宙
    ·2021-11-26
    Does this article mean that Moderna have more side effects than the rest?
    回复
    举报
    收起
    • Universe宇宙
      buy more covid stocks to huat big big?
      2021-11-26
      回复
      举报
    • Universe宇宙
      why there is no cancer vaccine?
      2021-11-26
      回复
      举报
    • Universe宇宙
      why there is no hiv vaccine?
      2021-11-26
      回复
      举报
    查看更多 2 条评论
  • Rachlim
    ·2021-11-26
    Should buy?
    回复
    举报
    收起
    • PrimRose
      Go for it
      2021-11-26
      回复
      举报
  • S土豪熊貓G
    ·2021-11-26
    Yes, go for Modena. Buy and hodl for long!
    回复
    举报
  • MHh
    ·2021-11-26
    For completeness, would also want the side effects and their severity reported. Possible to have the best of both worlds with any of these 5?
    回复
    举报
    收起
    • MHh回复Universe宇宙
      [Happy]
      2021-11-26
      回复
      举报
    • Universe宇宙回复MHh
      How I wonder if the smallpox vaccine creator can be still alive, maybe he will be able to create a 1 jab covid vaccine that will make us immune from covid virus and also without side effects too.
      2021-11-26
      回复
      举报
    • MHh回复Universe宇宙
      Seems so, with varying efficacy
      2021-11-26
      回复
      举报
    查看更多 2 条评论
  • Terc
    ·2021-11-26
    Ok
    回复
    举报
    收起
    • Terc
      ok
      2021-11-26
      回复
      举报
  • Sphere
    ·2021-11-26
    MRNA is more superior 
    回复
    举报
    收起
    • Sphere
      Up
      2021-11-26
      回复
      举报
  • pekss
    ·2021-11-26
    Surprised that the Russian vaccine is more effective than Pfizer’s
    回复
    举报
    收起
    • evepek
      Ok
      2021-11-26
      回复
      举报
  • TanZhenyu
    ·2021-11-26
    [财迷] 
    回复
    举报
    收起
    • Stylerz
      good
      2021-11-26
      回复
      举报
    • rae90
      ok
      2021-11-26
      回复
      举报
  • Jothebake
    ·2021-11-26
    Like
    回复
    举报
  • Ryoori
    ·2021-11-26
    Like pls
    回复
    举报
    收起
  • BowenDu
    ·2021-11-26
    Like pls thanks
    回复
    举报
    收起
    • Ryoori
      Ok
      2021-11-26
      回复
      举报
    • BowenDu
      like
      2021-11-26
      回复
      举报
  • kimlov
    ·2021-11-26
    Like
    回复
    举报
    收起
  • jingsheng
    ·2021-11-26
    cool
    回复
    举报
    收起
    • NTN80
      Ok
      2021-11-26
      回复
      举报
    • jingsheng
      cool
      2021-11-26
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24